Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of riluzole and levodopa for the treatment of Parkinson's disease

Combinations of riluzole and levodopa for the treatment of Parkinson's disease

US Patent 6387936 · Granted May 14, 2002

Estimated economic value: $2,079,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long non-coding RNAS (LNCRNAS) for the diagnosis and therapeutics of brain disor2025
Non-coding RNAS (NCRNA) for the diagnosis of cognitive disorders2023
H3 receptor antagonist for use in the treatment of alzheimer's disease2017
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agent2013
Transgenic animals exhibiting major disorders related to Alzheimer's disease2010
Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment o2001
Heterocyclic carboxamide compounds effective in the treatment of drug abuse2000
Use of pyrrolidine derivatives in the treatment of alcoholism1999
Application of riluzole in the treatment of mitochondrial diseases1997
Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-indu1996